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Abstract
Surgery is the cornerstone in primary endometrial cancer treatment, and with curative intent
it constitutes total hysterectomy and bilateral salpingo-oopherectomy. In addition, lympha-
denectomy is performed in selected patients dependent on a preoperative risk assessment.
Recent reports from the surgical approach to esophageal cancer reveal worse outcome
when esophagectomy is performed later in the week. On this basis, we set out to explore
weekday of surgery in relation to long-term outcome in 1302 endometrial cancer patients
prospectively included in the MoMaTEC multicenter study. Day of surgery was dichoto-
mized as early-week (Monday-Tuesday) or late-week (Wednesday-Friday), and evaluated
as a discrete variable. Adjusted for patient age, Body Mass Index (BMI), FIGO stage, and
histology, surgery performed later in the week was associated with 50.9% increased risk of
all-cause death (p = 0.029). Among high-stage patients (FIGO stage III and IV), 5-year dis-
ease-specific survival proportions were 53.0% for early-week operated vs. 40.2% for late-
week operated (p = 0.005 for difference). In multivariate survival analysis of high-stage
patients, late-week surgery correlated with an increased risk of disease-specific death by
88.7% and all-cause death by 76.4% (p<0.017). Evaluating only patients who underwent
lymphadenectomy, the adverse prognostic effect of being operated late-week remained for
both disease-specific and all-cause death (HR 2.151 and HR 1.912, p = 0.004). Whether
surgery was performed early- or late-week was not influenced by patient age, BMI,
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preoperative histology risk classification, FIGO stage or postoperative histology (all p>0.05).
In conclusion, endometrial cancer surgery conducted late-week is associated with worse
long-term outcome. Our findings are most evident among patients with higher FIGO stages,
and patients who underwent more extensive surgical procedure (lymphadenectomy). With
support from other studies, our results suggest that high-risk patients may benefit from sur-
gery earlier in the week.
Introduction
Endometrial cancer is the most common gynecological malignancy in the western world. The
prognosis is generally favorable, with 5-year disease-specific survival reported to 80–90% [1,
2]. However, endometrial cancer is a heterogeneous disease with great variations in aggres-
siveness, and among patients with presumed localized disease recurrences are observed in 15–
20% [3].
Surgery is the cornerstone in endometrial cancer treatment, and with curative intent consti-
tutes total hysterectomy and bilateral salpingo-oophorectomy. In addition, retroperitoneal
lymph node dissection is performed on a selection of patients dependent on a preoperative
risk assessment based on tumor characteristics as well as patient operability. Long-term prog-
nostic factors have been comprehensively investigated, the most important being the surgical
FIGO stage (International Federation of Gynecology and Obstetrics), myometrial invasion,
histological type, and differentiation grade [4].
Increased 30-day mortality in patients undergoing elective surgical procedures on Fridays
compared to earlier in the week has been demonstrated in several large cohort studies [5, 6].
Long-term prognostic impact of surgery weekday is less explored. Recent reports from esoph-
ageal cancer have demonstrated increased 5-year mortality among patients with potentially
curable disease when surgery is performed later in the week [7]. Furthermore, the prognostic
effect was found to be independent of reoperations and short-term (30-day) mortality, leaving
mechanisms involved unclear [8]. On this basis we set out to investigate long-term prognostic
impacts of weekday of surgery for endometrial cancer patients undergoing primary surgical
treatment.
Materials and methods
MoMaTEC study
After obtaining written informed consent, a total of 1372 patients from 10 centers were
included in the MoMaTEC study (Molecular Markers in Treatment of Endometrial Cancer,
Clinical Trial Identifier NCT00598845) between May 2001 and February 2013. The study
obtained Institutional review board approval (REKIII no 052.01), and has acquired approval of
the Norwegian Data Inspectorate (961478–2) and Norwegian Social Sciences Data services
(15501). More comprehensive descriptions of the MoMaTEC study have been given elsewhere
[9, 10].
Detailed clinicopathological data including age at diagnosis, date of primary surgical treat-
ment, treatment modality, tumor FIGO stage (2009 criteria), and histology from hysterectomy
specimens were recorded. Histological type and grade were categorized as endometrioid grade
1 or 2, endometrioid grade 3, or non-endometrioid histology. Preoperative curettage histology
reports were routinely categorized as high-risk (non-endometrioid, and histological grade 3
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endometrioid carcinomas) or low-risk (endometrioid carcinoma grade 1 or 2, hyperplasia and
benign endometrium). Participating centers applied local adjuvant treatment protocols, indi-
vidually tailored for each patient by the responsible physician. Follow-up data were collected
from patient records and correspondence with the respective physicians responsible for outpa-
tient controls.
Weekday of surgery and statistical analysis
For this study, the weekday of performed surgical procedure was obtained from recorded date
of primary surgery in a post hoc fashion. When exploring categorical associations between var-
iables and univariate survival analyses, day of surgery was dichotomized as either early-week
(Monday or Tuesday) or late-week (Wednesday through Friday), in concordance with the
study on esophageal cancer patients [7]. For multivariate survival analysis, weekday of surgery
was explored both categorical and as a discrete variable to evaluate for linear trends. For the
latter, the following coding was applied: 1 = Monday, 2 = Tuesday, 3 = Wednesday, 4 = Thurs-
day, 5 = Friday.
Statistical analyses were performed by SPSS, Statistical Package for the Social Sciences, ver-
sion 22.0 (IBM, Chicago, IL, USA). Associations between categorical variables were investi-
gated using the Pearson’s χ2-test. For comparisons of mean and median, a Student’s t-test and
Mann-Whitney U-test were applied as appropriate. Univariate survival analyses were con-
ducted by the Kaplan-Meier method with log-rank test for statistical significance, and multi-
variate survival analysis by the Cox proportional hazards model for Hazard Ratios (HR). All
tests were two-sided, and considered statistically significant when a probability of less than
0.05 was observed.
Results
Demographic, clinicopathological and treatment characteristics
Of the 1372 MoMaTEC patients treated for primary endometrial cancer by hysterectomy and
bilateral salpingo-oopherectomy, 1302 patients were included in the final analyses. Six patients
were discarded for being treated on a Sunday, and 64 patients were discarded due to lack of
follow-up information.
Patient age ranged from 25 to 98 years, with a mean of 65.9 years. Mean follow-up time was
35.8 months (range 0 to 105 months). Details of demographic, surgical and clinicopathological
characteristics are presented in Table 1, along with the corresponding distribution to weekday
of performed surgical procedure.
Most patients (96.1%) were treated Monday through Thursday (n = 1251). In detail, 26.8%
were treated on a Monday (n = 349), 28.7% on a Tuesday (n = 374), 22.0% on a Wednesday
(n = 286), 18.6% on a Thursday (n = 242) and 3.9% on a Friday (n = 51).
Lymphadenectomy was performed in 75.0% of cases (n = 977). Adjuvant treatment was
given to 29.9% of patients (n = 389) as various combinations of chemotherapy (n = 246) and/
or radiotherapy (n = 195), or hormonal treatment (n = 5). As portrayed in Table 1, comparing
patients with performed surgery early-week to late-week, no significant difference was
observed in regard to patient age, BMI, preoperative curettage risk classification, FIGO stage,
hysterectomy specimen histology (type and grade), myometrial infiltration or adjuvant treat-
ment (all p>0.05). An overview of specific adjuvant treatment received in relation to weekday
of primary surgery is presented for all patients, high-stage patients, and patients with per-
formed lymphadenectomy as supplementary material (S1 Table). We observed a tendency
towards higher rate of lymph node sampling late-week (78.8% of patients) compared with
early-week surgery (72.1% of patients) (p = 0.006). Furthermore, the number of nodes
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Table 1. Clinicopathological characteristics and demographics of endometrial cancer patients treated in the MoMaTEC* study.
Characteristics Total Cohort Weekday of Surgery p-valuea
Monday-Tuesday Wednesday-Friday
Number, % Number, % Number, %
Total 1302 100% 723 100% 579 100%
Preoperative characteristics
Age
<66 years 643 49.4% 365 50.5% 278 48.0%
 66 years 659 50.6% 358 49.5% 301 52.0% 0.376b
Body Mass Index (BMI)
<25 kg/m2 229 35.1% 123 36.9% 106 33.2%
25 kg/m2 423 64.9% 210 63.1% 213 66.8% 0.321c
Curettage histology classification
Low-risk 984 77.7% 548 77.4% 436 78.1%
High-risk 282 22.3% 160 22.6% 122 21.9% 0.775
Treatment details
Performed lymphadenectomy
Yes 977 75.0% 521 72.1% 456 78.8%
No 325 25.0% 202 27.9% 123 21.2% 0.006
Adjuvant treatmentd
No treatment 913 70.1% 512 70.8% 401 69.3%
Adjuvant treatment 389 29.9% 211 29.2% 178 30.7% 0.541
Postoperative characteristics
FIGO stagee
Stage I / II 1114 85.6% 626 86.6% 488 84.3%
Stage III / IV 188 14.4% 97 13.4% 91 15.7% 0.241
Histological subtype and grade
Endometrioid grade 1–2 898 69.5% 503 70.2% 395 68.6%
Endometrioid grade 3 156 12.1% 80 11.2% 76 13.2%
Non-endometrioid 239 18.5% 134 18.7% 105 18.2% 0.535
Myometrial infiltration
<50% 802 66.4% 454 68.3% 348 64.2%
50% 405 33.6% 211 31.7% 194 35.8% 0.137
Lymph node metastasisf
No 858 87.7% 454 87.1% 404 88.4%
Yes 120 12.3% 67 12.9% 53 11.6% 0.548
Clinicopathological characteristics and demographics related to weekday of surgery for 1302 endometrial cancer patients undergoing primary surgical
treatment. Weekday of surgery grouped as early-week (Monday and Tuesday) or late-week (Wednesday through Friday).
*MoMaTEC: Molecular Markers in Treatment of Endometrial cancer
aPearson χ2 test for two-sided significance.
bp = 0.131 when testing age as a continuous variable by Student’s t-test for equality of means.
cp = 0.779 when testing BMI as a continuous variable by Mann-Whitney U test for equality of medians.
dAdjuvant treatment comprising external radiation, internal radiation, chemotherapy, chemoradiation or hormonal treatment.
eFIGO = International Federation of Gynecology and Obstetrics (according to 2009 revision)
fLymph node metastasis evaluated among 977 patients with performed lymphadenectomy
https://doi.org/10.1371/journal.pone.0182223.t001
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removed was significantly higher when operated early-week (a mean of 16.9 removed nodes)
compared to late-week (a mean of 15.3 nodes, p = 0.022 for difference). However, there was no
significant difference in the presence of lymph node metastasis between early- or late-week
surgeries on postoperative histological scrutiny (p = 0.557).
Univariate survival analysis
Survival curves for univariate disease-specific survival proportions (DSS) are presented in Fig
1, and for overall survival as supplementary material (S1 Fig). For all patients, surgery per-
formed early-week was associated with borderline significant improved 5-year DSS propor-
tions compared to patients operated late-week (87.8% vs. 83.4%, respectively; p = 0.052) (Fig
1A). A difference was also observed for overall survival, however not statistically significant
(81.2% compared to 76.0%, p = 0.126) (S1A Fig).
To further explore the prognostic effects of weekday of surgery, subgroup analyses of low
FIGO stages (stage I and II patients) and high FIGO stages (stage III and IV patients) were per-
formed separately. Among patients with low FIGO stages, there was no statistical significant
difference in survival between early- and late-week operated for either DSS (Fig 1B) or overall
survival (S1B Fig). However, evaluating patients with high FIGO stages, a significant difference
in survival was observed. Five-year DSS proportions were 53.0% among early-week operated,
compared to 40.2% among late-week operated (p = 0.005, Fig 1C), and overall survival propor-
tions were 48.1% among early-week operated compared to 37.2% among late-week operated
(p = 0.004, S1C Fig). An overview of 5-year survival proportions according to each weekday of
performed surgery is presented as supplementary material (S2 Table).
Multivariate survival analysis
Results from multivariate Cox regression analyses are listed in S3 Table. Adjusted for patient
age, BMI, FIGO stage and histology, being operated late-week was associated with an increased
risk of all-cause death estimated to 50.9% (HR 1.509, 95% CI 1.042–2.186, p = 0.029). For dis-
ease-specific death, the increased risk was estimated to 52.1%, however of borderline signifi-
cance (HR 1.521, 95% CI 0.988–2.342, p = 0.057).
Subgroup analyses for patients with high FIGO stages (stage III and IV) are presented in
Table 2. Corrected for patient age and tumor histology, late-week surgery was associated with
an increased risk of disease-related death of 88.7% (HR 1.887, 95% CI 1.146–3.108, p = 0.013)
and all-cause death of 76.4% (HR 1.764, 95% CI 1.105–2.816, p = 0.017) (Table 2). Including
BMI as a covariate reduced the number of patients with complete data, but did not change the
significance of our results.
Multivariate survival analyses of high-stage patients with weekday of surgery as a discrete
variable are presented in Table 3. Corrected for age and tumor histology, an increment in
weekday of surgery with Monday as the reference day increased risk of disease-specific death
with an estimated 24.2% per day (HR 1.242, 95% CI 1.012–1.524, p = 0.038). The observed
increased risk was slightly smaller when analyzing death from any cause (HR 1.197, 95% CI
0.986–1.453, p = 0.069).
Assessing only patients with performed lymphadenectomy, late-week surgery remained an
independent prognostic factor (Table 4). Corrected for age, BMI, FIGO stage and histology,
late-week surgery associated with a significant increased risk of disease-specific death (HR
2.151, 95% CI 1.280–3.614, p = 0.004) and all-cause death (HR 1.912, 95% CI 1.232–2.968,
p = 0.004). Evaluating weekday of surgery as a discrete variable, the increased risk per incre-
mental weekday was estimated to 25.0% for disease-related death (HR 1.250, 95% CI 1.017–
Weekday of endometrial cancer surgical treatment and long-term outcome
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Fig 1. Disease-specific survival proportions in relation to weekday of surgery. Weekday of surgery
categorized as early-week (Monday and Tuesday) or late-week (Wednesday to Friday). A) All patients
(n = 1302), B) patients with low FIGO stages (n = 1114), and C) patients with high FIGO stages (n = 188). For
each category, the number of cases followed by the number of deaths is given in parenthesis. P-values are by
the Kaplan-Meier estimation by the log-rank test.
https://doi.org/10.1371/journal.pone.0182223.g001
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1.537, p = 0.034), and 22.5% for all-cause death (HR 1.225, 95% CI 1.024–1.466, p = 0.026)
with Monday as the reference category.
High-volume centers (n = 4) contributed the majority of patients (n = 1116) while low-
volume centers (n = 6) each contributed <100 patients each. When comparing centers, we
observed that low-volume centers had a tendency of performing surgery earlier in the week,
with 71.5% of patients operated early-week versus 52.9% for high-volume centers (p<0.001 for
difference). All analyses were therefore applied to patients from high-volume centers only, to
avoid this potential confounder. However, late-week surgery remained associated with an
increased risk of all-cause death (HR 1.533, 95% CI 1.056–2.224, p = 0.025) as well as disease-
specific death (HR 1.554, 95% CI 1.006–2.401, p = 0.047), corrected for FIGO stage, histology,
patient age and BMI. Evaluating patients of high-stage only from high-volume centers, the sig-
nificance of our results was not altered.
Table 2. Multivariate survival analyses of high stage endometrial cancer patients with weekday of surgery as a grouped variable.
Disease-specific survival Overall survival
Variable n Adjusted HR 95% CI P Adjusted HR 95% CI P
Age at primary treatmenta 187 1.037 1.014–1.061 0.002 1.047 1.024–1.070 <0.001
Histologyb
Endometrioid grade 1–2 76 1 - - 1 - -
Endometrioid grade 3 38 1.915 0.984–3.728 0.056 1.569 0.834–2.952 0.162
Non-endometrioid 73 1.918 1.082–3.400 0.026 1.725 1.018–2.923 0.043
Weekday of surgery
Monday-Tuesday 97 1 - - 1 - -
Wednesday-Friday 90 1.887 1.146–3.108 0.013 1.764 1.105–2.816 0.017
Multivariate disease-specific and overall survival analyses according to the Cox proportional hazards regression model for 187 endometrial cancer patients
with high FIGO stages (stage III-IV). Weekday of surgery was dichotomized as either early-week (Monday and Tuesday), or late-week (Wednesday through
Friday).
CI = Confidence Interval, FIGO = International Federation of Gynecology and Obstetrics, HR = Hazard Ratio.
aAge of primary treatment evaluated as a continuous variable.
bHistology evaluated in postoperatively acquired hysterectomy specimens
https://doi.org/10.1371/journal.pone.0182223.t002
Table 3. Multivariate survival analyses of high stage endometrial cancer patients with weekday of surgery as a discrete variable.
Disease-specific survival Overall survival
Variable n Adjusted HR 95% CI p-value Adjusted HR 95% CI p-value
Age at primary treatmenta 187 1.039 1.016–1.063 0.001 1.049 1.026–1.072 <0.001
Histologyb
Endometrioid grade 1–2 76 1 - - 1 - -
Endometrioid grade 3 38 1.884 0.969–3.662 0.062 1.550 0.826–2.910 0.173
Non-endometrioid 73 1.898 1.072–3.362 0.028 1.709 1.009–2.895 0.046
Weekday of surgeryc 187 1.242 1.012–1.524 0.038 1.197 0.986–1.453 0.069
Multivariate disease-specific and overall survival analyses according to the Cox proportional hazards regression model for 187 endometrial cancer patients
with high FIGO stages (FIGO stage III-IV). Weekday of surgery is evaluated as a discrete variable.
CI = Confidence Interval, FIGO = International Federation of Gynecology and Obstetrics, HR = Hazard Ratio.
aAge of primary treatment evaluated as a continuous variable.
bHistology evaluated in postoperatively acquired hysterectomy specimens
cWeekday of surgery evaluated as a discrete variable encoded 1 = Monday, 2 = Tuesday, 3 = Wednesday, 4 = Thursday, 5 = Friday
https://doi.org/10.1371/journal.pone.0182223.t003
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Discussion
Our results indicate that endometrial cancer surgery performed later in the week is associated
with worse long-term outcome. The prognostic effect is more evident among patients with
higher tumor stages, as well as patients with more extensive surgery performed (lymphade-
nectomy). Interestingly, our observed prognostic effects apply to both disease-specific as well
as all-cause death. With support from other studies, this suggests that complex patients with
advanced tumor stages and planned extensive surgery may benefit from being operated earlier
in the week.
Recently, a large population-based cohort study by Lagergren et al [7] evaluating
surgical resection of esophageal cancer found improved long-term outcome for patients
operated early-week compared to late-week. Noticeably, their observed prognostic impact
was more evident for patients with lower tumor stages. By comparison, our study finds the
prognostic effect to be more evident among patients with higher tumor stages, and one may
in this regard hypothesize that the surgical skills essential for long-term survival are most
crucial in advanced stage endometrial cancer, and low-stage esophageal cancer. Further-
more, while esophageal cancer surgery may be regarded as extensive (Lagergren et al report
an average operating time for esophagectomy of 6 ½ hours), endometrial cancer surgery
requires approximately a third of that operating time and is associated with low procedure-
related mortality. Our findings, demonstrated on a less extensive surgical procedure, are
in this regard an interesting supplement to the matter of surgery weekday and long-term
outcome.
A “weekend” effect of increased mortality for surgical procedures performed during the
weekend is well described in several studies [11–13]. However, a “weekday” effect is less
explored. Large cohort studies have demonstrated increased short-term (30-day) mortality in
Table 4. Multivariate survival analyses of all patients with performed lymphadenectomy.
Disease-specific survival Overall survival
Variable n Adjusted HR 95% CI p-value Adjusted HR 95% CI p-value
Age at primary treatmenta 529 1.044 1.016–1.072 0.002 1.053 1.029–1.077 <0.001
BMIa 529 0.982 0.936–1.030 0.453 1.000 0.961–1.040 0.982
FIGO stage (2009)
Stage I/II 443 1 - - 1 - -
Stage III/IV 86 6.545 3.809–11.245 <0.001 4.497 2.824–7.160 <0.001
Histologyb
Endometrioid grade 1–2 340 1 - - 1 - -
Endometrioid grade 3 75 4.429 1.925–10.188 <0.001 1.972 1.012–3.843 0.046
Non-endometrioid 114 6.991 3.419–14.298 <0.001 3.545 2.065–5.779 <0.001
Weekday of surgery
Monday-Tuesday 264 1 - - 1 - -
Wednesday-Friday 265 2.151 1.280–3.614 0.004 1.912 1.232–2.968 0.004
Multivariate disease-specific and overall survival analyses according to the Cox proportional hazards regression model for 529 endometrial cancer patients
with performed lymphadenectomy. Weekday of surgery was dichotomized as either early-week (Monday and Tuesday), or late-week (Wednesday through
Friday).
CI = Confidence Interval, FIGO = International Federation of Gynecology and Obstetrics, HR = Hazard Ratio.
aAge of primary treatment and BMI evaluated as continuous variables.
bHistology evaluated in postoperatively acquired hysterectomy specimens
https://doi.org/10.1371/journal.pone.0182223.t004
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patients undergoing surgery on a Friday compared to earlier in the week [5, 6]. The detected
increased short-term mortality has been attributed to reduction in clinical personnel [13, 14],
lack of seniority and experience [15], poorer availability of services later in the week [16], and
higher prevalence of complications within 48 hours of surgery [17]. However, it is also sug-
gested that the effect may largely be attributed to an unmeasured severity of illness rather than
differences in quality of care [18]. Contrasting these studies, our study demonstrates a long-
term prognostic effect, suggesting that the effects of weekday of surgery may last beyond the
immediate postoperative period. The cause is unknown. Interestingly, the follow-up study on
esophageal cancer by Lagergren et al found no association between weekday of surgery and
risk of reoperation, or increased 30-day mortality, suggesting other mechanisms affecting
long-term prognosis [8]. One may speculate that a combination of the above-mentioned fac-
tors in regard to patient care, as well as possible deterioration of individual surgical precision
towards the end of the week, come into play. However, it is also likely that unknown con-
founding variables account for the observed differences in survival between early- and late-
week operated.
Our study is not without limitations. Comorbid conditions are not accounted for in detail
in our population based prospective study design. However, by correcting for patient age
and BMI as surrogate markers for comorbidity, and by investigating both disease-specific as
well as all-cause mortality in our multivariate survival analyses, we have assumed to reduce
the effect of this potential confounder. In addition, although our surgical complication rates
and readmission rates are not known, biases related to unfavorable non-endometrial cancer
related events have been adjusted for by investigating disease-specific survival. Furthermore,
the quality of the follow-up in our multicenter study has an advantage over register-based
studies, with detailed patient follow-up data from the individually responsible physician.
Although our total sample size may be regarded as large (n = 1302), our observed differences
in survival were strongest for a smaller subset of patients with high stage (n = 188). This calls
for further support from other studies, and need for replication of our findings in larger sam-
ple sizes.
As illustrated in S2 Table, survival proportions seem to be better for patients operated Fri-
days compared to the days before. This conflicts with our postulated decreased survival
towards end-of-week. However, we attribute this to be due to a small number of patients oper-
ated on Fridays (n = 51 of a total of 1302 patients), which is further supported by the standard
error of the survival estimate for patients operated on Fridays being comparably large (S2
Table). Furthermore, as portrayed in Table 3, multivariate survival analyses with weekday of
surgery as a discrete variable (including Friday) showed a significant increased risk of disease-
specific death towards end-of-week.
We found no selection bias of patients to early- or late-week surgery depending on age,
BMI, preoperative curettage histology, FIGO stage, presence of lymph node metastasis, or
adjuvant treatment. As noted, we observed a collective trend of low-volume centers perform-
ing surgery earlier in the week. This is unlikely to have affected our results, as centers with
lower rates of patient contribution constituted a minority of total included patients (n = 186 of
1302), and as our prognostic findings were confirmed in subgroup analysis of high-volume
centers only.
In conclusion, our large population-based prospective multicenter study indicates that
endometrial cancer surgery conducted later in the week is associated with worse long-term
outcome. This effect was more evident among patients with higher tumor stages and more
extensive surgery performed (lymphadenectomy). With support from other patient cohorts,
this suggests that patients with advanced tumor stages and patients with planned extensive sur-
gery may benefit from being operated early-week.
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Supporting information
S1 Fig. Overall survival of endometrial cancer patients in relation to weekday of surgery,
categorized as early-week (Monday and Tuesday) or late-week (Wednesday to Friday). A)
All patients (n = 1302), B) patients with low FIGO stages (n = 1114), and C) patients with high
FIGO stage (n = 188). For each category, the number of cases followed by the number of
deaths is given in parenthesis. P-values are by the Kaplan-Meier estimation by the log-rank
test.
(TIF)
S1 Table. Specification of adjuvant treatment. Specification of adjuvant treatment grouped
according to weekday of primary surgical treatment, for all patients (n = 1302), high-stage
patients (n = 188) and patients with performed lymphadenectomy (n = 977).
aPearson χ2 test for two-sided significance.
(DOCX)
S2 Table. Weekday of surgery in relation to 5-year survival. Weekday of surgery in relation
to 5-year survival proportions for 1302 endometrial cancer patients.
(DOCX)
S3 Table. Multivariate survival analyses. Multivariate disease-specific and overall survival
analyses according to the Cox proportional hazards regression model for 645 patients with
endometrial cancer. Weekday of surgery was dichotomized as either early-week (Monday and
Tuesday), or late-week (Wednesday through Friday).
CI = Confidence Interval, FIGO = International Federation of Gynecology and Obstetrics,
HR = Hazard Ratio.
1Age of primary treatment and BMI evaluated as continuous variables.
2Histology evaluated in postoperatively acquired hysterectomy specimens.
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